Determining How Circadian Rhythm Regulates Sleep Fragmentations in Tauopathy
Principal Investigator
Masashi Tabuchi, PhD
Case Western Reserve University School of Medicine
Cleveland, OH, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2021 - June 30, 2025
Grant ID
A2021043S
Goals
The goal of this project is to elucidate how sodium channel dynamical states modulate tau pathology in circadian neurons to alter circadian rhythms and sleep.
Summary
In Aim 1, we will evaluate how inactivation states of voltage-gated sodium channels alter tau proteostasis, core clock system regulation, and circadian activity. In Aim 2, we will investigate the effect of pharmacological manipulations of inactivation states of voltage-gated sodium channels on clock neuron electrophysiology, sleep behavior, cognition, and lifespan in the adult Drosophila brain. In Aim 3, we will demonstrate that the inactivation states of voltage-gated sodium channels are altered in the iPS cells derived from human patients.
Unique and Innovative
By using Drosophila, the research proposal can precisely but rapidly capture behaviorally important molecular phenotypes of Alzheimer’s disease, and we can validate the conservation of these phenotypes in human iPS cell-derived neurons, by using our state-of-the-art data acquisition methodology of simultaneous electrophysiology and arousal/sleep measurements with sophisticated machine learning platforms to construct mathematical models to extract the features of the temporal structure of neural activity patterns. We believe that this approach is novel, and will attract worldwide attention.
Foreseeable Benefits
Completion of our study will help us address the gap in our knowledge of how alterations in voltage-gated channel states contribute to Alzheimer’s disease and related tauopathies, in the context of circadian regulation of sleep. Further, it will help pave the way towards the development of new therapeutic strategies for Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University